1.57BMarket Cap
23.85P/E TTM
Sarepta Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-07-31The current valuation score of Sarepta Therapeutics Inc is 8.23, ranking 64 out of 155 in the Pharmaceuticals industry. Its current P/E ratio is 23.85, which is 1449.67% below the recent high of 369.56 and 288.89% above the recent low of -45.04.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.